Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
RecruitingNot applicableNCT07227077
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to assess the best time to deliver a message to increase physical activity and how often participants will experience a pain episode in the 24 hours following their receipt of a message to increase physical activity.
Study details
- Official title
- An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Conditions
- Breast Cancer
- Cervical Cancer
- Bladder Cancer
- Colorectal Cancer
- Endometrial Cancer
- Lung Cancer
- Prostate Cancer
- Interventions
- Behavioral: Physical Activity Promotion Intervention
- Sponsor
- Medical College of Wisconsin
- Collaborators
- National Cancer Institute (NCI)
- Start date
- 2026-02-07
- Primary completion
- 2027-05-01
- Sex
- All
- Age range
- from 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Age greater than or equal to 65 years. 2. Patients with a history of bladder, breast, cervical, colorectal, endometrial, lung, and prostate cancer diagnosis and treatment. 3. Fluent in spoken and written English. 4. Patient has access to smartphone 5. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1. Patient has metastatic disease. 2. Patient has cancer recurrence.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07227077